Darvon, Darvocet Lawyer
Davon & Darvocet: Ineffective and Risky Drugs
Darvon and Darvocet are prescription painkillers that have been trusted by doctors for decades. Because the drugs have been around so long, many doctors consider them an effective, low-risk pain reliever. Research, however, has shown that they are mistaken on both counts.
Multiple Problems With Darvon and Darvocet
Darvon (propoxyphene) and Darvocet (propoxyphene combined with acetaminophen) have been shown to be ineffective and dangerous. The risks of these drugs far outweigh any potential benefits. The FDA itself concluded that propoxyphene alone has only "weak analgesic effects."
To learn more about the risks of these drugs please review the petition to remove them from the market. If you were harmed by Darvon, Darvocet or a generic brand of propoxyphene, please contact the Law Offices of J. Neal Rodgers, PLLC.
Darvon and Darvocet are:
- No better at relieving pain than two aspirin. Ibuprofen (Advil) offers more effective pain relief.
- Physically and psychologically addictive.
- Linked to potentially fatal heart problems.
- Responsible for thousands of deaths by accidental or intentional overdose.
- Banned in the UK.
More than 21 million prescriptions for propoxyphene were filled in 2007, making it one of the 25 most commonly prescribed drugs in the U.S.
Darvon was approved by the FDA in 1950. It would not meet today's far-more rigorous standards for drug approval.
If you or a member of your family has been seriously injured by these dangerous drugs, you need to speak to a lawyer experienced in cases involving dangerous and defective medications. Please contact dangerous drug attorney J. Neal Rodgers. Our law firm represents people harmed by defective drugs nationwide. Call toll free 888-471-2637 to arrange a free initial consultation.
A Decision to Put Patients at Risk
A Food and Drug Administration (FDA) advisory committee recommended in January 2009 that the FDA remove Darvon and Darvocet from the market because their significant risks outweigh their benefits. The FDA refused to ban the drug, but added a black box warning to the drug packaging.
